FDA approves Junshi, Coherus’ PD-1 toripalimab for nasopharyngeal carcinoma – Endpoints News October 30, 2023
Novartis’ $650M cash bet on a near-term FDA OK for BeiGene’s China PD-1? It just got delayed indefinitely – Endpoints News July 14, 2022July 14, 2022